TR-Dizin İndeksli Açık & Kapalı Erişimli Yayınlar
Permanent URI for this communityhttps://hdl.handle.net/11727/10755
Browse
3 results
Search Results
Item A Novel Therapeutic Approach for Renal Transplant Recipient with Septic Shock and Acute Kidney Injury: A Case Report(2021) Yesiler, Fatma Irem; Yurtsever, Beyza Meltem; Gedik, Ender; Zeyneloglu, Pinar; Haberal, Mehmet; 0000-0002-0612-8481; 0000-0002-4737-7660; 0000-0002-7175-207X; 0000-0002-3462-7632; AAJ-4212-2021; ABI-2971-2020; AAJ-8097-2021Extracorporeal blood purification (EBP) therapies, using oXiris (R) haemofilter, are popular and used globally in intensive care units for management of patients with septic acute kidney injury (AKI). Herein, we present a case of an immunocompromised renal transplant recipient with sepsis and AKI who was treated with continuous renal replacement therapy (CRRT) using oXiris (R) haemofilter. A 45-year-old female who underwent cadaveric renal transplantation in 2015 was admitted due to septic shock secondary to Escherichia coli urinary tract infection (bacteraemia) and acute respiratory distress syndrome (ARDS). Her acute physiology and chronic health assessment score was 23, sepsis-related organ failure score was 11 and Glasgow coma scale was 15. She was intubated because of moderate ARDS and administered vasopressors due to hemodynamic instability. For immunosuppressive therapy, methylprednisolone (40 mg q12h) was administered. Antimicrobial therapies, including intravenous meropenem, linezolid, trimethoprim-sulfamethoxazole, voriconazole and oseltamivir, were administered. She exhibited metabolic acidosis and septic AKI and was classified as Kidney Disease Improving Global Outcomes stage 3. Therefore, CRRT with oXiris (R) haemofilter was administered at the 11th hour after admission. A full recovery of transplant renal function and diuresis was observed 7 days after admission. She was transferred to ward after 9 days and discharged after 2 weeks, without the requirement of RRT. EBP is proposed as an adjuvant therapy for sepsis and AKI. Solid organ transplant recipients with septic AKI may benefit from early usage of oXiris (R) haemofilter with CRRT as a novel approach for improving survival and clinical outcomes.Item Effects of Minimal Flow Sevoflurane or Desflurane Anaesthesia on Hemodynamic Parameters, Body Temperature and Anaesthetic Consumption(2020) Taskın, Duygu; Gedik, Ender; Kayhan, Zeynep; 0000-0002-7175-207X; 0000-0003-0579-1115; 33103139; ABI-2971-2020; AAJ-4623-2021Objective: We aimed to compare minimal flow sevoflurane and desflurane anaesthesia in terms of hemodynamic parameters, body temperature, anaesthetic gas consumption and cost. Methods: 120 patients with ASA I-II (>18yo) who underwent elective surgery for longer than 60 min after general anaesthesia were randomized into two groups. The Drager Perseus (R) A500 workstation was used. Pre-oxygenation was performed for 3 min with 6 L min(-1) to 100% oxygen. Fractional inspirium oxygen concentration (FiO(2)) was reduced to 40%, fresh gas flow was 4 L min(-1) after intubation. Sevoflurane or desflurane was started at 1.5 minimal alveolar concentration (MAC). When the MAC value reached 0.9, fresh gas flow was reduced to 0.5 L min(-1), FiO(2) was increased to 68%. At the end of the surgery, the vaporizer was switched off, the fresh gas flow was increased (4 L min(-1), FiO(2) 100%). When the train-of-four (TOF) ratio was 100%, extubation was carried out. Results: There were no differences in patient characteristics and initial hemodynamic parameters of the groups. There were statistically significant differences between the times to reach 0.9 MAC, extubation and eye opening; anaesthetic, O-2 and air consumption in both groups. Conclusion: With minimal flow, the time to reach target MAC, time to extubation and eye opening were significantly faster for desflurane and anaesthetic, oxygen and air consumption in desflurane anaesthesia were less than sevoflurane. Thus, we can say that desflurane has faster anaesthetic induction and recovery time with lower anaesthetic consumption than sevoflurane.Item A Pregnant Woman with Jaundice in the Intensive Care Unit(A Pregnant Woman with Jaundice in the Intensive Care Unit, 2020) Yesiler, Fatma Irem; Sahinturk, Helin; Gunakan, Emre; Gedik, Ender; Zeyneloglu, Pinar; 0000-0003-0159-4771; 0000-0001-8854-8190; AAJ-1419-2021Acute fatty liver of pregnancy (AFLP) is a life-threatening disorder characterized by maternal liver failure, and it occurs in the third trimester of pregnancy or postpartum period. The resultant effects include coagulopathy, electrolyte abnormalities, and the multiple organ dysfunction syndrome (MODS), which may require liver transplantation. Therefore, pregnant women having MODS should be managed in an intensive care unit (ICU) with multidisciplinary inputs to facilitate the appropriate supportive care. We present a successful case report of a pregnant women admitted to the ICU with jaundice and MODS without the need for liver transplantation and organ support therapies. A 20-year-old patient in her first pregnancy at 31 weeks gestation who presented with nausea, vomiting, and jaundice was admitted to our hospital. She was referred from a rural medical center (a center 608 kilometers away) to the ICU due to the possible diagnosis of acute liver failure requiring liver transplantation. Acute physiology and chronic health assessment score was 12, sepsis related organ failure score was 8, and Glasgow coma scale was 15 on ICU admission. AFLP was considered in the patient and an emergency delivery was performed by caesarean section. She recovered with intensive care support after pregnancy delivery without the need for liver transplantation. The patient was discharged from the ICU and hospital after 6 and 10 days, respectively. AFLP should be suspected in the differential diagnosis of a pregnant woman with jaundice and hyperbilirubinemia who is admitted to the ICU in the third trimester of pregnancy or postpartum period. Intensivist should not delay in the diagnosis of AFLP due to its morbid complications and high mortality. Early diagnosis, prompt pregnancy delivery, and intensive care support in the peripartum and postpartum periods may improve maternal and fetal outcomes